Conejero I

Psychiatry, CHU Nimes, Nimes

3 papers

ArticlePsilocybin

One dose of Psilocybin modulates Brain Activity among Depressive patients : Preliminary Neuroimaging Results from the PSILODAC Study

Pastre M, Pereira F, Gibert T +6

Europe PMC2026
ArticleKetamine

Esketamine use in real-world clinical practice in patients with treatment-resistant depression.

Conejero I, Alvarez García R, Porras-Segovia A +7

Europe PMC2025
ArticlePsilocybin

Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.

Prouzeau D, Conejero I, Voyvodic PL +3

Europe PMC2022